Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Other Operating Expenses (2022 - 2025)

Precision Biosciences (DTIL) has disclosed Other Operating Expenses for 4 consecutive years, with -$390000.0 as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses fell 114.29% to -$390000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$421000.0 through Dec 2025, up 3.44% year-over-year, with the annual reading at -$421000.0 for FY2025, 3.44% up from the prior year.
  • Other Operating Expenses for Q4 2025 was -$390000.0 at Precision Biosciences, down from $3000.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $72000.0 in Q2 2023, with the low at -$524000.0 in Q4 2023.
  • Average Other Operating Expenses over 4 years is -$89866.7, with a median of -$19000.0 recorded in 2022.
  • Peak annual rise in Other Operating Expenses hit 253.19% in 2023, while the deepest fall reached 2657.89% in 2023.
  • Over 4 years, Other Operating Expenses stood at -$19000.0 in 2022, then tumbled by 2657.89% to -$524000.0 in 2023, then surged by 65.27% to -$182000.0 in 2024, then crashed by 114.29% to -$390000.0 in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at -$390000.0, $3000.0, and -$25000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.